Viral Transmission

Commercial Immunoglobulin Preparations Don't Transmit TTV Infection

Published in Blood Weekly, January 24th, 2002

by Sonia Nichols, senior medical writer - Individuals who must take immunoglobulin therapy because of immunodeficiency are at little risk for acquiring transfusion-transmitted virus (TTV) infection, researchers in Italy say.

TTV infection, initially detected in a patient suffering from posttransfusion hepatitis, is believed to be transmitted via the blood, but definitive information about its transmission route is still unclear, as it has also been detected in the sera of healthy people not receiving blood transfusions.

The virus's prevalence is relatively high among blood donors in some regions. Researchers have detected TTV DNA in commercial...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (2002-01-24)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry